Table 2. Quality assessment of included studies evaluating the efficacy of nalmefene in the treatment of adult alcohol dependence (main analysis).
Study | Sequence Generation | Allocation Concealment | Blinding | Incomplete Outcome Data | Selective Outcome Reporting | Other Source of Bias |
---|---|---|---|---|---|---|
Gual et al. (12023A) | Low risk | Low risk | Low risk | High risk | Low risk | Low risk |
Mann et al. (12014A) | Low risk | Low risk | Low risk | High risk | Low risk | Low risk |
Karhuvaara et al. (CPH-101-801) | Low risk | Low risk | Low risk | High risk | Low risk | Low risk |
CPH-101-0701 | Low risk | Low risk | Low risk | High risk | Low risk | Low risk |
van den Brink et al. (12013A) | Low risk | Low risk | Low risk | High risk | Low risk | Low risk |
Each study was assessed for methodological quality using a standardized critical appraisal instrument (the Cochrane Collaboration tool for assessing risk of bias).